228 related articles for article (PubMed ID: 24626992)
1. RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland.
McDonald L; Ferrari N; Terry A; Bell M; Mohammed ZM; Orange C; Jenkins A; Muller WJ; Gusterson BA; Neil JC; Edwards J; Morris JS; Cameron ER; Blyth K
Dis Model Mech; 2014 May; 7(5):525-34. PubMed ID: 24626992
[TBL] [Abstract][Full Text] [Related]
2. RUNX2 in mammary gland development and breast cancer.
Ferrari N; McDonald L; Morris JS; Cameron ER; Blyth K
J Cell Physiol; 2013 Jun; 228(6):1137-42. PubMed ID: 23169547
[TBL] [Abstract][Full Text] [Related]
3. A role for Runx2 in normal mammary gland and breast cancer bone metastasis.
Shore P
J Cell Biochem; 2005 Oct; 96(3):484-9. PubMed ID: 16052475
[TBL] [Abstract][Full Text] [Related]
4. Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer.
Owens TW; Rogers RL; Best S; Ledger A; Mooney AM; Ferguson A; Shore P; Swarbrick A; Ormandy CJ; Simpson PT; Carroll JS; Visvader J; Naylor MJ
Cancer Res; 2014 Sep; 74(18):5277-5286. PubMed ID: 25056120
[TBL] [Abstract][Full Text] [Related]
5. Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.
Davies BR; Platt-Higgins AM; Schmidt G; Rudland PS
Am J Pathol; 1999 Jul; 155(1):303-14. PubMed ID: 10393862
[TBL] [Abstract][Full Text] [Related]
6. Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.
Das K; Leong DT; Gupta A; Shen L; Putti T; Stein GS; van Wijnen AJ; Salto-Tellez M
Eur J Cancer; 2009 Sep; 45(13):2239-48. PubMed ID: 19632824
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.
Sum EY; Segara D; Duscio B; Bath ML; Field AS; Sutherland RL; Lindeman GJ; Visvader JE
Proc Natl Acad Sci U S A; 2005 May; 102(21):7659-64. PubMed ID: 15897450
[TBL] [Abstract][Full Text] [Related]
8. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
Sampayo R; Recouvreux S; Simian M
Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
[TBL] [Abstract][Full Text] [Related]
9. PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development.
Grinman DY; Boras-Granic K; Takyar FM; Dann P; Hens JR; Marmol C; Lee J; Choi J; Chodosh LA; Sola MEG; Wysolmerski JJ
Breast Cancer Res; 2022 Apr; 24(1):30. PubMed ID: 35440032
[TBL] [Abstract][Full Text] [Related]
10. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
11. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
[TBL] [Abstract][Full Text] [Related]
12. Runx2 contributes to the regenerative potential of the mammary epithelium.
Ferrari N; Riggio AI; Mason S; McDonald L; King A; Higgins T; Rosewell I; Neil JC; Smalley MJ; Sansom OJ; Morris J; Cameron ER; Blyth K
Sci Rep; 2015 Oct; 5():15658. PubMed ID: 26489514
[TBL] [Abstract][Full Text] [Related]
13. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland.
Gao B; Qu Y; Han B; Nagaoka Y; Katsumata M; Deng N; Bose S; Jin L; Giuliano AE; Cui X
Sci Rep; 2017 Oct; 7(1):14017. PubMed ID: 29070831
[TBL] [Abstract][Full Text] [Related]
15. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
16. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.
Gonzalez-Suarez E; Jacob AP; Jones J; Miller R; Roudier-Meyer MP; Erwert R; Pinkas J; Branstetter D; Dougall WC
Nature; 2010 Nov; 468(7320):103-7. PubMed ID: 20881963
[TBL] [Abstract][Full Text] [Related]
17. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
18. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression.
Inman CK; Shore P
J Biol Chem; 2003 Dec; 278(49):48684-9. PubMed ID: 14506237
[TBL] [Abstract][Full Text] [Related]
19. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model.
Jäger R; Werling U; Rimpf S; Jacob A; Schorle H
Mol Cancer Res; 2003 Oct; 1(12):921-9. PubMed ID: 14573793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
